We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Punctuating Messages Encoded in Human Genome with Transposable Elements

A recent study shows that critical aspects of this regulatory program are encoded by genomic sequence elements that were previously thought to be mere "junk DNA" with no important functions.
News

MorphoSys and G7 Therapeutics Sign Alliance

Collaboration broadens MorphoSys' capabilities to target novel antigen classes.
News

Uncovering Genetic Factors in Leukemia

Northwestern Medicine scientists have discovered how a gene linked to leukemia functions, a finding that may have important implications for children with Down syndrome who have a higher risk of developing the blood cancer.
News

Mirati Therapeutics, MedImmune Partner

The companies have announced that have announced that they have entered into an exclusive clinical trial collaboration.
News

Cloud Pharmaceuticals, Genomeon Partner

Relationship to help Cloud Pharmaceuticals identify companion biomarkers effective in targeting cancers and other genetically influenced diseases.
News

ZKT gGmbH Awarded AMG Manufacturing Licence for Platelet Lysate

Turbo-drive for stem cell cultivation.
News

arGEN-X and University of Bern Enter into License Agreement

Collaboration demonstrates potential of ARGX-110 in overcoming treatment resistance in chronic myelogenous leukemia (CML).
News

MorphoSys's Partner Heptares Initiates Proprietary Therapeutic Antibody Program

Successful discovery alliance combines two leading technologies.
News

Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration

Companies agree to jointly advance PD-1 and other new immuno-oncology antibodies.
News

Capsugel Expanding Pharmaceutical Product Development and Manufacturing Capabilities

Investment accommodates the company’s growing pipeline of pharmaceutical customer projects and brings a broader range of technologies closer to its European customers.
Advertisement